Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

Por Kasimir-Bauer, Sabine, Bittner, Ann-Kathrin, König, Lisa, Reiter, Katharina, Keller, Thomas, Kimmig, Rainer, Hoffmann, Oliver
Publicado no Breast Cancer Res (2016)

B3-lesions of the breast and cancer risk - an analysis of mammography screening patients

Por HOFFMANN, OLIVER, STAMATIS, GESINA ATHINA, BITTNER, ANN-KATHRIN, ARNOLD, GEORG, SCHNABEL, ROLF, KRÜGER, KARLGEORG, KIMMIG, RAINER, HEUBNER, MARTIN
Publicado no Mol Clin Oncol (2016)

Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?

Por Kasimir-Bauer, Sabine, Reiter, Katharina, Aktas, Bahriye, Bittner, Ann-Kathrin, Weber, Stephan, Keller, Thomas, Kimmig, Rainer, Hoffmann, Oliver
Publicado no Sci Rep (2016)

Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy

Por König, Lisa, Kasimir-Bauer, Sabine, Bittner, Ann-Kathrin, Hoffmann, Oliver, Wagner, Bettina, Santos Manvailer, Luis Felipe, Kimmig, Rainer, Horn, Peter A., Rebmann, Vera
Publicado no Oncoimmunology (2017)